News & Updates

Show Multimedia Only
Neoadjuvant cycles do not alter perioperative nivolumab benefit in resectable NSCLC
Neoadjuvant cycles do not alter perioperative nivolumab benefit in resectable NSCLC
19 Apr 2024 byJairia Dela Cruz

Treatment with nivolumab plus chemotherapy before surgery followed by nivolumab after surgery yields superior outcomes for patients with resectable nonsmall cell lung cancer (NSCLC) as compared with placebo plus chemotherapy, regardless of the number of completed neoadjuvant cycles, according to an exploratory analysis of the CHECKMATE 77T trial.

Neoadjuvant cycles do not alter perioperative nivolumab benefit in resectable NSCLC
19 Apr 2024
Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis
Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis
19 Apr 2024

Analysing molecular signatures from active skin lesions aids in the stratification of patients with contact dermatitis (CD) and helps identify those with allergic CD, suggests a study.

Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis
19 Apr 2024